CD163 and cancer: Pan-cancer analysis of the TCGA&GTEx database showed that CD206 and CD163 mRNA expression was heterogeneous among 33 malignant tumor tissues, but both were significantly highly expressed in PAAD tissues (Figures S1A, B; Table S1).